These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7242187)

  • 41. Management of an unsuspected case of malignant hyperpyrexia.
    Thiagarajah S
    Middle East J Anaesthesiol; 1986 Feb; 8(4):269-75. PubMed ID: 3960004
    [No Abstract]   [Full Text] [Related]  

  • 42. Malignant hyperpyrexia and isoflurane. A case report.
    Thomas DW; Dev VJ; Whitehead MJ
    Br J Anaesth; 1987 Sep; 59(9):1196-8. PubMed ID: 3663443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current concepts of malignant hyperthermia.
    Jafek BW; Solomons CC; Masson NC; Mahowald MC; Gumprecht TF
    Otolaryngol Head Neck Surg; 1981; 89(6):891-7. PubMed ID: 6801585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
    Shukry M; Guruli ZV; Ramadhyani U
    Paediatr Anaesth; 2006 Apr; 16(4):462-5. PubMed ID: 16618304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium.
    Verburg MP; Oerlemans FT; van Bennekom CA; Gielen MJ; de Bruyn CH; Crul JF
    Acta Anaesthesiol Scand; 1984 Feb; 28(1):1-8. PubMed ID: 6711253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A survey for prevention and treatment of malignant hyperthermia in Taiwan.
    Yip WH; Mingi CL; Ooi SJ; Chen SC; Chiang YY
    Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):147-51. PubMed ID: 15551892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
    Flewellen EH; Nelson TE
    Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dantrolene therapy for malignant hyperthermia.
    Hoff B; Taylor C; Kruel J
    Crit Care Med; 1980 Nov; 8(11):699-700. PubMed ID: 7428399
    [No Abstract]   [Full Text] [Related]  

  • 54. Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.
    Xu X
    Med Hypotheses; 2019 Mar; 124():118-120. PubMed ID: 30798905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
    Spiess-Kiefer C; Hippius H
    Fortschr Neurol Psychiatr; 1986 May; 54(5):158-70. PubMed ID: 2426164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of porcine malignant hyperthermia. A review based on experimental studies.
    Hall GM; Lucke JN; Lister D
    Anaesthesia; 1975 May; 30(3):308-17. PubMed ID: 238411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case report of malignant hyperthermia in a 14-month-old boy].
    Semmler A; Rieger C; Lesinski R
    Anaesthesiol Reanim; 1994; 19(1):21-2. PubMed ID: 8141960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.